Hong Kong stock market anomaly | BeiGene (06160.HK) opens over 3% higher. The joint Phase III clinical study of BeiGene and MSD Achieves positive results in chemotherapy.

According to the Wise Finance APP, BeiGene (06160.HK) opened more than 3% higher and rose 3.53% as of the time of publication, reaching 223.2 Hong Kong dollars, with a turnover of 11.96 million Hong Kong dollars.